Live from the Lab | Vaccination against heart disease with Felix Nettersheim, M.D.
Jan 25, 2024La Jolla Institute for Immunology (LJI) '23 SPARK winner Felix Nettersheim, M.D., discusses how he is deploying novel therapeutic strategies to develop a clinically effective heart disease vaccine. Heart disease has been the leading cause of death in the United States since the 1950s. A major cause of cardiovascular disease is an uncontrolled autoimmune attack against blood vessels. Accumulating evidence suggests that a vaccine with cholesterol particles can dampen this autoimmune process. However, such vaccines elicit a considerably weaker response compared to vaccines against bacteria or viruses. In this Live from the Lab discussion, Dr. Nettersheim will explore how his research may dampen the misguided immune response that is responsible for cardiovascular disease, and could lead to important vaccine discoveries – ultimately working towards Life Without Disease®. La Jolla Institute for Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. We look forward to having you join us and welcome you to share this opportunity with family and friends that may be interested in learning more about LJI. Additional information on Dr. Nettersheim's research can be found at lji.org/spark23-felix. LJI's Live from the Lab webinar series gives viewers an opportunity to receive a virtual behind-the-scenes look as LJI scientists and leadership dive into the immune system and its role in fighting COVID-19 and other global health challenges such as cancer and autoimmune disease.